Pilot Study of an Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- CLN3-related Disorders
- 发起方
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- 入组人数
- 11
- 试验地点
- 1
- 主要终点
- Participants With Adverse Events
- 状态
- 终止
- 最后更新
- 去年
概览
简要总结
Background:
CLN3 involves vision loss observed around the preschool years, with eventual progression to blindness within 1-3 years. Researchers want to test an assistive device that may help children with CLN3 or with non-CLN3 related blindness.
Objective:
To learn if it is safe, easy, and useful for children with CLN3 or with non-CLN3 related blindness to use the OrCam.
Eligibility:
People aged 6-18 years who have either CLN3-related disease or non-CLN3 related blindness.
Design:
Participants will be screened with the following:
Medical history
Physical exam
Family history
Eye exam and vision tests. They will get eyedrops to dilate their eyes.
Psychological and neurocognitive tests. They will be asked questions and observed for how they do various tasks, such as talking, playing, writing, drawing, and solving problems.
Hearing tests. They may wear headphones or earplugs. Electrodes may be taped to their head.
Blood samples
Skin biopsy, if needed
Cheek cell, saliva, or urine samples
The OrCam is the size of and weighs about half as much as a pack of gum. It is attached to eyeglass frames by magnets. Participants will do tasks before and after they have been trained on the OrCam. They will do these tasks without or with using the OrCam.
Participants will be given an OrCam to use for 1 week or 1 month. They will have check-in sessions with the study team.
Participants and/or their caregivers will be asked about abilities, behaviors, social skills, learning methods, intelligence, and health-related quality of life.
Participants samples may be used for genetic testing and/or to make a type of stem cell.
Participation will last for 1-5 weeks.
详细描述
Study Description: This is a pilot study of an augmentative visual device, OrCam MyEye 2 (OrCam), in pediatric individuals with CLN3-related conditions or low vision. We hypothesize that, given the relatively simple design and operating procedure of the device, the use of the OrCam by study participants will be safe and feasible. We also hypothesize that the device will enhance their ability to obtain visually based information. Objectives: Primary: Assess the safety and feasibility of OrCam use by children with CLN3 or low vision. Endpoints: Primary: 1. Adverse events during the use of OrCam 2. Feasibility test 3. Feasibility questionnaire The assessment periods will be 1 week at study site.
研究者
入排标准
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Participants With Adverse Events
时间窗: 1 week
Number of participants with adverse events related to the use of OrCam MyEye 2. Adverse events were collected from parental report.